QCG
OM icon

Quadrant Capital Group’s Outset Medical OM Stock Holding History

Quadrant Capital Group’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6
Closed -$498 – 2756
2023
Q4 		$498 Buy
+6
New +$488 ﹤0.01% 2614
2023
Q3 		– Sell
-27
Closed -$8.73K – 2747
2023
Q2 		$8.73K Hold
27
– – ﹤0.01% 2053
2023
Q1 		$7.45K Sell
27
-4
-13% -$1.47K ﹤0.01% 2131
2022
Q4 		$12K Buy
31
+17
+121% +$4.79K ﹤0.01% 1861
2022
Q3 		$3K Buy
14
+2
+17% +$536 ﹤0.01% 2290
2022
Q2 		$3K Buy
+12
New +$5.16K ﹤0.01% 2129
2022
Q1 		– Sell
-1
Closed – – 2635
2021
Q4 		$0 Hold
1
– – ﹤0.01% 2642
2021
Q3 		$1K Hold
1
– – ﹤0.01% 2359
2021
Q2 		$1K Buy
+1
New +$764 ﹤0.01% 2302

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Quadrant Capital Group's OM Position: Q1 2024 in Review

Quadrant Capital Group sold out of Outset Medical (OM) in Q1 2024, closing a stake of 6 shares — an estimated $498 sold.

Quadrant Capital Group first reported a position in OM in Q2 2021 and held it in 9 quarters. The position peaked at $12K in Q4 2022. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • Quadrant Capital Group reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 6 Outset Medical shares in Q1 2024, an estimated $498.
  • Quadrant Capital Group first reported a position in Outset Medical in Q2 2021 and held it in 9 quarters.
  • Quadrant Capital Group's Outset Medical position peaked at $12K in Q4 2022.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Quadrant Capital Group's 13F filing for Q1 2024, filed 15 May 2024.